News
-
Get better sleep
Wednesday | Sep 10 2025RESTIN 2mg melatonin modified release tablets help offer a better quality sleep.
-
Design your space
Wednesday | Sep 10 2025PHARMACIUM creates work spaces that reflect your working style and improve efficiencies throughout your pharmacy, with a focus on dispensary operations.
-
Relationships key to success
Wednesday | Sep 10 2025WITH recent high levels of interest in pharmacy ownership, especially among younger pharmacists (PD 05 Sep), a timely interview with seasoned pharmacist, business mentor, and former board member Ivan Grauer is ideally placed to provide aspiring owners with valuable advice.
-
GLP-1 RA pregnancy risks overlooked by young women
Wednesday | Sep 10 2025MOST Australian women of reproductive age prescribed GLP-1 receptor agonists, such as Ozempic, are not using effective contraception, despite risks during pregnancy, according to a study published in the MJA.
-
-
Mag-Sup powder – a better way to absorb magnesium
Wednesday | Sep 10 2025MAG-SUP powder is a high absorption magnesium supplement for use in magnesium deficiencies.
-
APC welcomes NSW full-scope training
Tuesday | Sep 9 2025THE Australian Pharmacy Council (APC) has applauded the announcement from NSW Premier Chris Minns that the University of Technology Sydney and University of Newcastle are aiming to offer full-scope training for community pharmacists from 2026 (PD 05 Sep).
-
Teens seek pharmacist advice
Tuesday | Sep 9 2025NEW research conducted by Monash University has revealed that community pharmacists are well-placed and keen to provide adolescents with contraception information and services, but felt they needed additional training in this area.
-
BP cuffs wrong size for many
Tuesday | Sep 9 2025FINDINGS from a recent Australian study investigating blood pressure (BP) monitor cuffs supplied with in-home devices have raised concerns that many Australians are at risk of inaccurate BP readings due to an inappropriately sized cuff.
-
Advanz agrees to PI/CMI changes
Tuesday | Sep 9 2025ADVANZ Pharma, sponsor for antidepressants Tofranil and Parnate, has agreed to update its consumer medicines information (CMI) and product information (PI) documents to better reflect current best practice - the first pharma to do so.
